speb/financial-data huggingface dataset:
ISRG.TO cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -1200000.00
ISRG.TO cash_flow (quarterly, 2025-09-30) — Change In Payable: 24600000.00
ISRG.TO cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 59300000.00
ISRG.TO cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -107100000.00
ISRG.TO cash_flow (quarterly, 2025-09-30) — Change In Receivables: 9900000.00
ISRG.TO cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -314400000.00
ISRG.TO cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 9900000.00
ISRG.TO cash_flow (quarterly, 2025-09-30) — Changes In Cash: -601000000.00
ISRG.TO balance_sheet (quarterly, 2025-09-30) — Common Stock: 400000.00
ISRG.TO balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 16929700000.00
ISRG.TO cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -1913300000.00
ISRG.TO income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 842700000.00
ISRG.TO balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 437300000.00
ISRG.TO balance_sheet (quarterly, 2025-09-30) — Current Assets: 8525300000.00
ISRG.TO balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 491100000.00
ISRG.TO balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 491100000.00
ISRG.TO balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 1803200000.00
ISRG.TO cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 88000000.00
ISRG.TO cash_flow (quarterly, 2025-09-30) — Deferred Tax: 88000000.00
ISRG.TO cash_flow (quarterly, 2025-09-30) — Depreciation: 156700000.00
ISRG.TO cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 142200000.00
ISRG.TO cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 142200000.00
ISRG.TO income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 704400000.00
ISRG.TO income_statement (quarterly, 2025-09-30) — EBIT: 759700000.00
ISRG.TO income_statement (quarterly, 2025-09-30) — EBITDA: 901900000.00
ISRG.TO cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 4000000.00
ISRG.TO cash_flow (quarterly, 2025-09-30) — End Cash Position: 2849500000.00
ISRG.TO cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -1843000000.00
ISRG.TO balance_sheet (quarterly, 2025-09-30) — Finished Goods: 1025500000.00
ISRG.TO cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 735600000.00
ISRG.TO cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: -14900000.00
ISRG.TO balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 26500000.00
ISRG.TO balance_sheet (quarterly, 2025-09-30) — Goodwill: 348100000.00
ISRG.TO balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 362600000.00
ISRG.TO income_statement (quarterly, 2025-09-30) — Gross Profit: 1662400000.00
ISRG.TO income_statement (quarterly, 2025-09-30) — Interest Income: 95500000.00
ISRG.TO income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 95500000.00
ISRG.TO balance_sheet (quarterly, 2025-09-30) — Inventory: 1781900000.00
ISRG.TO balance_sheet (quarterly, 2025-09-30) — Invested Capital: 16929700000.00
ISRG.TO cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 401000000.00
ISRG.TO balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 3523700000.00
ISRG.TO balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 3523700000.00
ISRG.TO balance_sheet (quarterly, 2025-09-30) — Minority Interest: 112400000.00
ISRG.TO income_statement (quarterly, 2025-09-30) — Minority Interests: -4800000.00
ISRG.TO cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: 0.00
ISRG.TO cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -1913300000.00
ISRG.TO income_statement (quarterly, 2025-09-30) — Net Income: 704400000.00
ISRG.TO income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 704400000.00
ISRG.TO income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 709200000.00
ISRG.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 704400000.00
ISRG.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 704400000.00
ISRG.TO cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 709200000.00
ISRG.TO income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 709200000.00
ISRG.TO income_statement (quarterly, 2025-09-30) — Net Interest Income: 95500000.00
ISRG.TO cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 506400000.00
ISRG.TO income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 95500000.00
ISRG.TO cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -19700000.00
ISRG.TO balance_sheet (quarterly, 2025-09-30) — Net PPE: 5150900000.00
ISRG.TO cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -105400000.00
ISRG.TO balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 16567100000.00
ISRG.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 978900000.00
ISRG.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 79400000.00
ISRG.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Revenue: 79400000.00
ISRG.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 978900000.00
ISRG.TO income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 901900000.00
ISRG.TO income_statement (quarterly, 2025-09-30) — Normalized Income: 704400000.00
ISRG.TO cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 841000000.00
ISRG.TO cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -14900000.00
ISRG.TO income_statement (quarterly, 2025-09-30) — Operating Income: 759700000.00
ISRG.TO income_statement (quarterly, 2025-09-30) — Operating Revenue: 2505100000.00
ISRG.TO balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 354900000.00
ISRG.TO balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 282700000.00
ISRG.TO balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 26500000.00
ISRG.TO balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 14500000.00
ISRG.TO cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 9600000.00
ISRG.TO balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 810400000.00
ISRG.TO balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 195900000.00
ISRG.TO balance_sheet (quarterly, 2025-09-30) — Other Receivables: 288800000.00
ISRG.TO balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 2102200000.00
ISRG.TO balance_sheet (quarterly, 2025-09-30) — Payables: 419300000.00
ISRG.TO balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 856600000.00
ISRG.TO balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 455500000.00
ISRG.TO balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
ISRG.TO balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 168000000.00
ISRG.TO income_statement (quarterly, 2025-09-30) — Pretax Income: 855200000.00
ISRG.TO cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 90000000.00
ISRG.TO cash_flow (quarterly, 2025-09-30) — Purchase Of Business: 0.00
ISRG.TO cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -99100000.00
ISRG.TO cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -105400000.00
ISRG.TO balance_sheet (quarterly, 2025-09-30) — Raw Materials: 531200000.00
ISRG.TO balance_sheet (quarterly, 2025-09-30) — Receivables: 1383900000.00
ISRG.TO balance_sheet (quarterly, 2025-09-30) — Receivables Adjustments Allowances: -24900000.00
ISRG.TO income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 842700000.00
ISRG.TO income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 142200000.00
ISRG.TO cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -1913300000.00
ISRG.TO income_statement (quarterly, 2025-09-30) — Research And Development: 329400000.00
ISRG.TO balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 6424000000.00
ISRG.TO cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 605500000.00
ISRG.TO income_statement (quarterly, 2025-09-30) — Selling General And Administration: 573300000.00
ISRG.TO balance_sheet (quarterly, 2025-09-30) — Share Issued: 354900000.00
ISRG.TO cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 203500000.00
ISRG.TO balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 16929700000.00
ISRG.TO balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 16567100000.00
ISRG.TO income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
ISRG.TO income_statement (quarterly, 2025-09-30) — Tax Provision: 146000000.00
ISRG.TO income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.17
ISRG.TO balance_sheet (quarterly, 2025-09-30) — Total Assets: 19351800000.00
ISRG.TO balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 16929700000.00
ISRG.TO balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 17042100000.00
ISRG.TO income_statement (quarterly, 2025-09-30) — Total Expenses: 1745400000.00
ISRG.TO balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 2309700000.00
ISRG.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 10826500000.00
ISRG.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 506500000.00
ISRG.TO income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 759700000.00
ISRG.TO balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 128100000.00
ISRG.TO balance_sheet (quarterly, 2025-09-30) — Tradeand Other Payables Non Current: 231200000.00
ISRG.TO balance_sheet (quarterly, 2025-09-30) — Work In Process: 225200000.00
ISRG.TO balance_sheet (quarterly, 2025-09-30) — Working Capital: 6722100000.00
ISRG.TO income_statement (annual, 2025-12-31) — +Operating Expense: 3696800000.00
ISRG.TO income_statement (quarterly, 2025-12-31) — +Operating Expense: 1040000000.00
ISRG.TO income_statement (annual, 2025-12-31) — +Total Revenue: 10064700000.00
ISRG.TO income_statement (quarterly, 2025-12-31) — +Total Revenue: 2866200000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Accounts Payable: 255100000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 255100000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Accounts Receivable: 1527300000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 1527300000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -2276500000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -2276500000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 10768500000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 10768500000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -29900000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -29900000.00
ISRG.TO cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 62400000.00
ISRG.TO cash_flow (quarterly, 2025-12-31) — Amortization Cash Flow: 52500000.00
ISRG.TO cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: 62400000.00
ISRG.TO cash_flow (quarterly, 2025-12-31) — Amortization Of Intangibles: 52500000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 3099200000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 3099200000.00
ISRG.TO income_statement (annual, 2025-12-31) — Basic Average Shares: 8924869553.00
ISRG.TO income_statement (quarterly, 2025-12-31) — Basic Average Shares: 8874856274.00
ISRG.TO income_statement (annual, 2025-12-31) — Basic EPS: 0.32
ISRG.TO income_statement (quarterly, 2025-12-31) — Basic EPS: 0.09
ISRG.TO cash_flow (annual, 2025-12-31) — Beginning Cash Position: 2062400000.00
ISRG.TO cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 2849500000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 2833900000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 2833900000.00
ISRG.TO cash_flow (annual, 2025-12-31) — Capital Expenditure: -539800000.00
ISRG.TO cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -162500000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Capital Stock: 400000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Capital Stock: 400000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 3368000000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 3368000000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 5934900000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 5934900000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Cash Equivalents: 2853100000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Cash Equivalents: 2853100000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Cash Financial: 514900000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Cash Financial: 514900000.00
ISRG.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -2364100000.00
ISRG.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -137500000.00
ISRG.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 665800000.00
ISRG.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -209400000.00
ISRG.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 3030500000.00
ISRG.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 892500000.00
ISRG.TO cash_flow (annual, 2025-12-31) — Change In Account Payable: 57900000.00
ISRG.TO cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -39100000.00
ISRG.TO cash_flow (annual, 2025-12-31) — Change In Inventory: -1063400000.00
ISRG.TO cash_flow (quarterly, 2025-12-31) — Change In Inventory: -253000000.00
ISRG.TO cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: 34100000.00
ISRG.TO cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: 28900000.00
ISRG.TO cash_flow (annual, 2025-12-31) — Change In Other Working Capital: 187900000.00
ISRG.TO cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 140300000.00
ISRG.TO cash_flow (annual, 2025-12-31) — Change In Payable: 57900000.00
ISRG.TO cash_flow (quarterly, 2025-12-31) — Change In Payable: -39100000.00
ISRG.TO cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 57900000.00
ISRG.TO cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 41100000.00
ISRG.TO cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -187100000.00
ISRG.TO cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 61800000.00
ISRG.TO cash_flow (annual, 2025-12-31) — Change In Receivables: -301700000.00
ISRG.TO cash_flow (quarterly, 2025-12-31) — Change In Receivables: -267500000.00
ISRG.TO cash_flow (annual, 2025-12-31) — Change In Working Capital: -1272300000.00
ISRG.TO cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -248400000.00
ISRG.TO cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -301700000.00
ISRG.TO cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -267500000.00
ISRG.TO cash_flow (annual, 2025-12-31) — Changes In Cash: 1332200000.00
ISRG.TO cash_flow (quarterly, 2025-12-31) — Changes In Cash: 545600000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Common Stock: 400000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Common Stock: 400000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Common Stock Equity: 17824000000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 17824000000.00
ISRG.TO cash_flow (annual, 2025-12-31) — Common Stock Payments: -2295300000.00
ISRG.TO cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -201000000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Construction In Progress: 638100000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 638100000.00
ISRG.TO income_statement (annual, 2025-12-31) — Cost Of Revenue: 3422400000.00
ISRG.TO income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 961900000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 470600000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 470600000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Current Assets: 9779500000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Current Assets: 9779500000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 506700000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 506700000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 506700000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 506700000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Current Liabilities: 2006200000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 2006200000.00
ISRG.TO cash_flow (annual, 2025-12-31) — Deferred Income Tax: 19100000.00
ISRG.TO cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: -39500000.00
ISRG.TO cash_flow (annual, 2025-12-31) — Deferred Tax: 19100000.00
ISRG.TO cash_flow (quarterly, 2025-12-31) — Deferred Tax: -39500000.00
ISRG.TO cash_flow (annual, 2025-12-31) — Depreciation: 614700000.00
ISRG.TO cash_flow (quarterly, 2025-12-31) — Depreciation: 168400000.00
ISRG.TO cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 677100000.00
ISRG.TO cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 220900000.00
ISRG.TO cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 677100000.00
ISRG.TO cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 220900000.00
ISRG.TO income_statement (annual, 2025-12-31) — Diluted Average Shares: 9069908061.00
ISRG.TO income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 9012392790.00
ISRG.TO income_statement (annual, 2025-12-31) — Diluted EPS: 0.31
ISRG.TO income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.09
ISRG.TO income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 2856000000.00
ISRG.TO income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 794800000.00
ISRG.TO income_statement (annual, 2025-12-31) — EBIT: 2945500000.00
ISRG.TO income_statement (quarterly, 2025-12-31) — EBIT: 864300000.00
ISRG.TO income_statement (annual, 2025-12-31) — EBITDA: 3622600000.00
ISRG.TO income_statement (quarterly, 2025-12-31) — EBITDA: 1085200000.00
ISRG.TO cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 12800000.00
ISRG.TO cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 12300000.00
ISRG.TO cash_flow (annual, 2025-12-31) — End Cash Position: 3407400000.00
ISRG.TO cash_flow (quarterly, 2025-12-31) — End Cash Position: 3407400000.00
ISRG.TO cash_flow (annual, 2025-12-31) — Financing Cash Flow: -2364100000.00
ISRG.TO cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -137500000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Finished Goods: 991000000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Finished Goods: 991000000.00
ISRG.TO cash_flow (annual, 2025-12-31) — Free Cash Flow: 2490700000.00
ISRG.TO cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 730000000.00
ISRG.TO cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -57200000.00
ISRG.TO cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: -14900000.00
ISRG.TO cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of Business: -1000000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 43300000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 43300000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Goodwill: 370300000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Goodwill: 370300000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 381400000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 381400000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 1557200000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 1557200000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Gross PPE: 7618900000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Gross PPE: 7618900000.00
ISRG.TO income_statement (annual, 2025-12-31) — Gross Profit: 6642300000.00
ISRG.TO income_statement (quarterly, 2025-12-31) — Gross Profit: 1904300000.00
ISRG.TO cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 537900000.00
ISRG.TO income_statement (annual, 2025-12-31) — Interest Income: 365900000.00
ISRG.TO income_statement (quarterly, 2025-12-31) — Interest Income: 91300000.00
ISRG.TO income_statement (annual, 2025-12-31) — Interest Income Non Operating: 365900000.00
ISRG.TO income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 91300000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Inventory: 1840000000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Inventory: 1840000000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Invested Capital: 17824000000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Invested Capital: 17824000000.00
ISRG.TO cash_flow (annual, 2025-12-31) — Investing Cash Flow: 665800000.00
ISRG.TO cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -209400000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 3099200000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 3099200000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Investments And Advances: 3099200000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 3099200000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Land And Improvements: 479700000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 479700000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 1570600000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 1570600000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Minority Interest: 117700000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Minority Interest: 117700000.00
ISRG.TO income_statement (annual, 2025-12-31) — Minority Interests: -20600000.00
ISRG.TO income_statement (quarterly, 2025-12-31) — Minority Interests: -4700000.00
ISRG.TO cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: -13900000.00
ISRG.TO cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: -12700000.00
ISRG.TO cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -2295300000.00
ISRG.TO cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -201000000.00
ISRG.TO income_statement (annual, 2025-12-31) — Net Income: 2856000000.00
ISRG.TO income_statement (quarterly, 2025-12-31) — Net Income: 794800000.00
ISRG.TO income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 2856000000.00
ISRG.TO income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 794800000.00
ISRG.TO income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 2876600000.00
ISRG.TO income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 799500000.00
ISRG.TO income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 2856000000.00
ISRG.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 794800000.00
ISRG.TO income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 2856000000.00
ISRG.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 794800000.00
ISRG.TO cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 2876600000.00
ISRG.TO cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 799500000.00
ISRG.TO income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 2876600000.00
ISRG.TO income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 799500000.00
ISRG.TO income_statement (annual, 2025-12-31) — Net Interest Income: 365900000.00
ISRG.TO income_statement (quarterly, 2025-12-31) — Net Interest Income: 91300000.00
ISRG.TO cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 1219500000.00
ISRG.TO cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -34200000.00
ISRG.TO income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 365900000.00
ISRG.TO income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 91300000.00
ISRG.TO cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -419100000.00
ISRG.TO cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -13100000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Net PPE: 5342400000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Net PPE: 5342400000.00
ISRG.TO cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -539800000.00
ISRG.TO cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -162500000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 17442600000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 17442600000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 1018600000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 1018600000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 91400000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 91400000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Revenue: 91400000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Revenue: 91400000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 1018600000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 1018600000.00
ISRG.TO income_statement (annual, 2025-12-31) — Normalized EBITDA: 3622600000.00
ISRG.TO income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 1085200000.00
ISRG.TO income_statement (annual, 2025-12-31) — Normalized Income: 2856000000.00
ISRG.TO income_statement (quarterly, 2025-12-31) — Normalized Income: 794800000.00
ISRG.TO cash_flow (annual, 2025-12-31) — Operating Cash Flow: 3030500000.00
ISRG.TO cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 892500000.00
ISRG.TO cash_flow (annual, 2025-12-31) — Operating Gains Losses: -58200000.00
ISRG.TO cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -15900000.00
ISRG.TO income_statement (annual, 2025-12-31) — Operating Income: 2945500000.00
ISRG.TO income_statement (quarterly, 2025-12-31) — Operating Income: 864300000.00
ISRG.TO income_statement (annual, 2025-12-31) — Operating Revenue: 10064700000.00
ISRG.TO income_statement (quarterly, 2025-12-31) — Operating Revenue: 2866200000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 355100000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 355100000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Other Current Assets: 376400000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 376400000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 43300000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 43300000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 11100000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 11100000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 837600000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 837600000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 225800000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 225800000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Other Properties: 2096600000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Other Properties: 2096600000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Other Receivables: 100900000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Other Receivables: 100900000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 2566900000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 2566900000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Payables: 380500000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Payables: 380500000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 851100000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 851100000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 648400000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 648400000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
ISRG.TO income_statement (annual, 2025-12-31) — Pretax Income: 3311400000.00
ISRG.TO income_statement (quarterly, 2025-12-31) — Pretax Income: 955600000.00
ISRG.TO cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 350300000.00
ISRG.TO cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 76600000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Properties: 0.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
ISRG.TO cash_flow (annual, 2025-12-31) — Purchase Of Business: -13900000.00
ISRG.TO cash_flow (quarterly, 2025-12-31) — Purchase Of Business: -12700000.00
ISRG.TO cash_flow (annual, 2025-12-31) — Purchase Of Investment: -1215900000.00
ISRG.TO cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -425000000.00
ISRG.TO cash_flow (annual, 2025-12-31) — Purchase Of PPE: -539800000.00
ISRG.TO cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -162500000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Raw Materials: 561100000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Raw Materials: 561100000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Receivables: 1628200000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Receivables: 1628200000.00
ISRG.TO income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 3422400000.00
ISRG.TO income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 961900000.00
ISRG.TO income_statement (annual, 2025-12-31) — Reconciled Depreciation: 677100000.00
ISRG.TO income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 220900000.00
ISRG.TO cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -2295300000.00
ISRG.TO cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -201000000.00
ISRG.TO income_statement (annual, 2025-12-31) — Research And Development: 1311800000.00
ISRG.TO income_statement (quarterly, 2025-12-31) — Research And Development: 352900000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Retained Earnings: 7011800000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 7011800000.00
ISRG.TO cash_flow (annual, 2025-12-31) — Sale Of Investment: 2435400000.00
ISRG.TO cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 390800000.00
ISRG.TO income_statement (annual, 2025-12-31) — Selling General And Administration: 2385000000.00
ISRG.TO income_statement (quarterly, 2025-12-31) — Selling General And Administration: 687100000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Share Issued: 355100000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Share Issued: 355100000.00
ISRG.TO cash_flow (annual, 2025-12-31) — Stock Based Compensation: 788200000.00
ISRG.TO cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 203300000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Stockholders Equity: 17824000000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 17824000000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Tangible Book Value: 17442600000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 17442600000.00
ISRG.TO income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
ISRG.TO income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
ISRG.TO income_statement (annual, 2025-12-31) — Tax Provision: 434800000.00
ISRG.TO income_statement (quarterly, 2025-12-31) — Tax Provision: 156100000.00
ISRG.TO income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.13
ISRG.TO income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.16
ISRG.TO balance_sheet (annual, 2025-12-31) — Total Assets: 20458700000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Total Assets: 20458700000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Total Capitalization: 17824000000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 17824000000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 17941700000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 17941700000.00
ISRG.TO income_statement (annual, 2025-12-31) — Total Expenses: 7119200000.00
ISRG.TO income_statement (quarterly, 2025-12-31) — Total Expenses: 2001900000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 2517000000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 2517000000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 10679200000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 10679200000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 510800000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 510800000.00
ISRG.TO income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 2945500000.00
ISRG.TO income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 864300000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Total Tax Payable: 125400000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 125400000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Tradeand Other Payables Non Current: 193600000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Tradeand Other Payables Non Current: 193600000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Work In Process: 287900000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Work In Process: 287900000.00
ISRG.TO balance_sheet (annual, 2025-12-31) — Working Capital: 7773300000.00
ISRG.TO balance_sheet (quarterly, 2025-12-31) — Working Capital: 7773300000.00
ISRG.TO income_statement (quarterly, 2026-03-31) — +Operating Expense: 975200000.00
ISRG.TO income_statement (quarterly, 2026-03-31) — +Total Revenue: 2770800000.00
ISRG.TO balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 332900000.00
ISRG.TO balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 1391100000.00
ISRG.TO balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 11059900000.00
ISRG.TO cash_flow (quarterly, 2026-03-31) — Amortization Cash Flow: 21100000.00
ISRG.TO cash_flow (quarterly, 2026-03-31) — Amortization Of Intangibles: 21100000.00
ISRG.TO balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 3461900000.00
ISRG.TO income_statement (quarterly, 2026-03-31) — Basic Average Shares: 8874856274.00
ISRG.TO income_statement (quarterly, 2026-03-31) — Basic EPS: 0.09
ISRG.TO cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 3407400000.00
ISRG.TO cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -103300000.00
ISRG.TO balance_sheet (quarterly, 2026-03-31) — Capital Stock: 400000.00
ISRG.TO balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 2006500000.00
ISRG.TO balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 4517300000.00
ISRG.TO balance_sheet (quarterly, 2026-03-31) — Cash Equivalents: 1206900000.00
ISRG.TO balance_sheet (quarterly, 2026-03-31) — Cash Financial: 799600000.00
ISRG.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -1353700000.00
ISRG.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -914500000.00
ISRG.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 911900000.00
ISRG.TO cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 73900000.00
ISRG.TO cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: -284700000.00
ISRG.TO cash_flow (quarterly, 2026-03-31) — Change In Inventory: -266600000.00
ISRG.TO cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: 30700000.00
ISRG.TO cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 46100000.00
ISRG.TO cash_flow (quarterly, 2026-03-31) — Change In Payable: 73900000.00
ISRG.TO cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -210800000.00
ISRG.TO cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -269300000.00
ISRG.TO cash_flow (quarterly, 2026-03-31) — Change In Receivables: 25100000.00
ISRG.TO cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -644800000.00
ISRG.TO cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: 25100000.00
ISRG.TO cash_flow (quarterly, 2026-03-31) — Changes In Cash: -1356300000.00
ISRG.TO balance_sheet (quarterly, 2026-03-31) — Common Stock: 400000.00
ISRG.TO balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 17474500000.00
ISRG.TO cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -1123200000.00
ISRG.TO income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 940300000.00
ISRG.TO balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 492200000.00
ISRG.TO balance_sheet (quarterly, 2026-03-31) — Current Assets: 8809500000.00
ISRG.TO balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 559500000.00
ISRG.TO balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 559500000.00
ISRG.TO balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 1911000000.00
ISRG.TO cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 339300000.00
ISRG.TO cash_flow (quarterly, 2026-03-31) — Deferred Tax: 339300000.00
ISRG.TO cash_flow (quarterly, 2026-03-31) — Depreciation: 178900000.00
ISRG.TO cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 200000000.00
ISRG.TO cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 200000000.00
ISRG.TO income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 8997388807.00
ISRG.TO income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.09
ISRG.TO income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 821500000.00
ISRG.TO income_statement (quarterly, 2026-03-31) — EBIT: 855300000.00
ISRG.TO income_statement (quarterly, 2026-03-31) — EBITDA: 1055300000.00
ISRG.TO cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: 1000000.00
ISRG.TO cash_flow (quarterly, 2026-03-31) — End Cash Position: 2052100000.00
ISRG.TO cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -1353700000.00
ISRG.TO balance_sheet (quarterly, 2026-03-31) — Finished Goods: 1046800000.00
ISRG.TO cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 808600000.00
ISRG.TO cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: -10200000.00
ISRG.TO cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of Business: -7900000.00
ISRG.TO balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 16500000.00
ISRG.TO balance_sheet (quarterly, 2026-03-31) — Goodwill: 613200000.00
ISRG.TO balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 780700000.00
ISRG.TO income_statement (quarterly, 2026-03-31) — Gross Profit: 1830500000.00
ISRG.TO income_statement (quarterly, 2026-03-31) — Interest Income: 85100000.00
ISRG.TO income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 85100000.00
ISRG.TO balance_sheet (quarterly, 2026-03-31) — Inventory: 1945100000.00
ISRG.TO balance_sheet (quarterly, 2026-03-31) — Invested Capital: 17474500000.00
ISRG.TO cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -914500000.00
ISRG.TO balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 3461900000.00
ISRG.TO balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 3461900000.00
ISRG.TO balance_sheet (quarterly, 2026-03-31) — Minority Interest: 122700000.00
ISRG.TO income_statement (quarterly, 2026-03-31) — Minority Interests: -4500000.00
ISRG.TO cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: -482200000.00
ISRG.TO cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -1123200000.00
ISRG.TO income_statement (quarterly, 2026-03-31) — Net Income: 821500000.00
ISRG.TO income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 821500000.00
ISRG.TO income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 826000000.00
ISRG.TO income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 821500000.00
ISRG.TO income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 821500000.00
ISRG.TO cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 826000000.00
ISRG.TO income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 826000000.00
ISRG.TO income_statement (quarterly, 2026-03-31) — Net Interest Income: 85100000.00
ISRG.TO cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -329000000.00
ISRG.TO income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 85100000.00
ISRG.TO cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -352300000.00
ISRG.TO balance_sheet (quarterly, 2026-03-31) — Net PPE: 5447900000.00
ISRG.TO cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -103300000.00
ISRG.TO balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 16693800000.00
ISRG.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 683800000.00
ISRG.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 104000000.00
ISRG.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Revenue: 104000000.00
ISRG.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 683800000.00
ISRG.TO income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 1055300000.00
ISRG.TO income_statement (quarterly, 2026-03-31) — Normalized Income: 821500000.00
ISRG.TO cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 911900000.00
ISRG.TO cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -18100000.00
ISRG.TO income_statement (quarterly, 2026-03-31) — Operating Income: 855300000.00
ISRG.TO income_statement (quarterly, 2026-03-31) — Operating Revenue: 2770800000.00
ISRG.TO balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 354400000.00
ISRG.TO balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 337200000.00
ISRG.TO balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: 16500000.00
ISRG.TO balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 167500000.00
ISRG.TO balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 927200000.00
ISRG.TO balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 278500000.00
ISRG.TO balance_sheet (quarterly, 2026-03-31) — Other Receivables: 352700000.00
ISRG.TO balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 2510800000.00
ISRG.TO balance_sheet (quarterly, 2026-03-31) — Payables: 488600000.00
ISRG.TO balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 980800000.00
ISRG.TO balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 370700000.00
ISRG.TO balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
ISRG.TO balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 298800000.00
ISRG.TO income_statement (quarterly, 2026-03-31) — Pretax Income: 940400000.00
ISRG.TO cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 121800000.00
ISRG.TO cash_flow (quarterly, 2026-03-31) — Purchase Of Business: -528200000.00
ISRG.TO cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -911300000.00
ISRG.TO cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -103300000.00
ISRG.TO balance_sheet (quarterly, 2026-03-31) — Raw Materials: 591400000.00
ISRG.TO balance_sheet (quarterly, 2026-03-31) — Receivables: 1711100000.00
ISRG.TO balance_sheet (quarterly, 2026-03-31) — Receivables Adjustments Allowances: -32700000.00
ISRG.TO income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 940300000.00
ISRG.TO income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 200000000.00
ISRG.TO cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -1123200000.00
ISRG.TO income_statement (quarterly, 2026-03-31) — Research And Development: 361900000.00
ISRG.TO balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 6397700000.00
ISRG.TO cash_flow (quarterly, 2026-03-31) — Sale Of Business: 46000000.00
ISRG.TO cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 582300000.00
ISRG.TO income_statement (quarterly, 2026-03-31) — Selling General And Administration: 613300000.00
ISRG.TO balance_sheet (quarterly, 2026-03-31) — Share Issued: 354400000.00
ISRG.TO cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 209500000.00
ISRG.TO balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 17474500000.00
ISRG.TO balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 16693800000.00
ISRG.TO income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
ISRG.TO income_statement (quarterly, 2026-03-31) — Tax Provision: 114400000.00
ISRG.TO income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.12
ISRG.TO balance_sheet (quarterly, 2026-03-31) — Total Assets: 20111000000.00
ISRG.TO balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 17474500000.00
ISRG.TO balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 17597200000.00
ISRG.TO income_statement (quarterly, 2026-03-31) — Total Expenses: 1915500000.00
ISRG.TO balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 2513800000.00
ISRG.TO balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 11301500000.00
ISRG.TO balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 602800000.00
ISRG.TO income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 855300000.00
ISRG.TO balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 155700000.00
ISRG.TO balance_sheet (quarterly, 2026-03-31) — Tradeand Other Payables Non Current: 220300000.00
ISRG.TO balance_sheet (quarterly, 2026-03-31) — Work In Process: 306900000.00
ISRG.TO balance_sheet (quarterly, 2026-03-31) — Working Capital: 6898500000.00
ISRG.TO income_statement (quarterly, 2026-06-30) — +Operating Expense: 988500000.00
ISRG.TO income_statement (quarterly, 2026-06-30) — +Total Revenue: 2892300000.00
ISRG.TO balance_sheet (quarterly, 2026-06-30) — Accounts Payable: 277200000.00
ISRG.TO balance_sheet (quarterly, 2026-06-30) — Accounts Receivable: 1433400000.00
ISRG.TO balance_sheet (quarterly, 2026-06-30) — Additional Paid In Capital: 11325000000.00
ISRG.TO cash_flow (quarterly, 2026-06-30) — Amortization Cash Flow: 38800000.00
ISRG.TO cash_flow (quarterly, 2026-06-30) — Amortization Of Intangibles: 38800000.00
ISRG.TO balance_sheet (quarterly, 2026-06-30) — Available For Sale Securities: 3409300000.00
ISRG.TO income_statement (quarterly, 2026-06-30) — Basic Average Shares: 8854850963.00
ISRG.TO income_statement (quarterly, 2026-06-30) — Basic EPS: 0.09
ISRG.TO cash_flow (quarterly, 2026-06-30) — Beginning Cash Position: 2052100000.00